217 related articles for article (PubMed ID: 10354742)
1. [Effects of mitotane therapy in dogs with pituitary dependent Cushing syndrome on the adrenal gland size--an ultrasonographic study].
Hörauf A; Reusch C
Schweiz Arch Tierheilkd; 1999; 141(5):239-45. PubMed ID: 10354742
[TBL] [Abstract][Full Text] [Related]
2. Results of non-selective adrenocorticolysis by o,p'-DDD in 129 dogs with pituitary-dependent hyperadrenocorticism.
den Hertog E; Braakman JC; Teske E; Kooistra HS; Rijnberk A
Vet Rec; 1999 Jan; 144(1):12-7. PubMed ID: 10028568
[TBL] [Abstract][Full Text] [Related]
3. [Mitotane treatment in a dog with a recurring adrenocortical carcinoma--a case report].
Keiser M; Flückiger M; Gardelle O; Reusch C
Schweiz Arch Tierheilkd; 1999; 141(6):279-85. PubMed ID: 10389485
[TBL] [Abstract][Full Text] [Related]
4. [Ultrasonography of the adrenal gland in dogs].
Kaser-Hotz B; Saunders HM
Schweiz Arch Tierheilkd; 1995; 137(6):258-64. PubMed ID: 7481716
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonography of the adrenal gland.
Schelling CG
Probl Vet Med; 1991 Dec; 3(4):604-17. PubMed ID: 1802272
[TBL] [Abstract][Full Text] [Related]
6. o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
Peterson ME
J Am Vet Med Assoc; 1983 Mar; 182(5):527-8. PubMed ID: 6300010
[No Abstract] [Full Text] [Related]
7. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
[TBL] [Abstract][Full Text] [Related]
8. Problems associated with medical therapy of canine hyperadrenocorticism.
Nichols R
Probl Vet Med; 1990 Dec; 2(4):551-6. PubMed ID: 2134073
[TBL] [Abstract][Full Text] [Related]
9. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic evaluation of the adrenal glands in dogs.
Barthez PY; Nyland TG; Feldman EC
J Am Vet Med Assoc; 1995 Nov; 207(9):1180-3. PubMed ID: 7559065
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane.
Peterson ME; Kintzer PP
Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):255-72. PubMed ID: 9076906
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucocorticoid administration on adrenal gland size and sonographic appearance in beagle dogs.
Pey P; Daminet S; Smets PM; Duchateau L; Travetti O; Saunders JH
Vet Radiol Ultrasound; 2012; 53(2):204-9. PubMed ID: 22092685
[TBL] [Abstract][Full Text] [Related]
13. Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytoma.
Bennett PF; Norman EJ
Aust Vet J; 1998 Feb; 76(2):101-3. PubMed ID: 9578778
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of pituitary-dependent hyperadrenocorticism in dogs.
Peterson ME; Kintzer PP
Semin Vet Med Surg Small Anim; 1994 Aug; 9(3):127-31. PubMed ID: 7938931
[No Abstract] [Full Text] [Related]
15. Changes in ultrasonographic appearance of adrenal glands in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
Mantis P; Lamb CR; Witt AL; Neiger R
Vet Radiol Ultrasound; 2003; 44(6):682-5. PubMed ID: 14703251
[TBL] [Abstract][Full Text] [Related]
16. A comparison of factors that influence survival in dogs with adrenal-dependent hyperadrenocorticism treated with mitotane or trilostane.
Helm JR; McLauchlan G; Boden LA; Frowde PE; Collings AJ; Tebb AJ; Elwood CM; Herrtage ME; Parkin TD; Ramsey IK
J Vet Intern Med; 2011; 25(2):251-60. PubMed ID: 21352377
[TBL] [Abstract][Full Text] [Related]
17. [Experiences with Lysodren therapy of Cushing's syndrome in the dog (1)].
Opitz M; Lettow E; Loppnow H; Grevel V
Tierarztl Prax; 1983; 11(3):369-84. PubMed ID: 6636131
[No Abstract] [Full Text] [Related]
18. [Experiences with Lysodren treatment of Cushing's syndrome in dogs].
Opitz M; Lettow E; Loppnow H; Grevel V
Tierarztl Prax; 1983; 11(4):507-20. PubMed ID: 6658774
[No Abstract] [Full Text] [Related]
19. Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).
Peterson ME
Vet Clin North Am Small Anim Pract; 2001 Sep; 31(5):1005-14, viii. PubMed ID: 11570123
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory parameters for the control of the course of therapy of canine Cushing's syndrome].
Reusch C; Hähnle B
Tierarztl Prax; 1991 Feb; 19(1):102-6. PubMed ID: 1646492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
